Background Each month, the number of transplant candidates added to the waiting list exceeds the number of transplantations performed, and many outpatients deteriorate to require transplantation urgently. The current list of 2400 candidates and the average wait of 8 months continue to increase.
Methods and Results To determine the size at which the outpatient and critical candidate pools will stabilize, population models were constructed using current statistics for donor hearts, candidate listing, sudden death, and outpatient decline to urgent status and revised to predict the impact of alterations in policies of candidate listing. If current practices continue, within 48 months the predicted list will stabilize as the sum of an estimated 270 hospitalized candidates, among whom, together with newly listed urgent candidates, all hearts will be distributed and 3700 outpatient candidates with virtually no chance of transplantation unless they deteriorate to an urgent status. Decreasing the upper age limit now to 55 years would reduce the number listed each month by 30% and result within T he success of transplantation has stimulated referrals of patients with heart failure. In January 1992, there were 2400 patients listed for cardiac transplantation compared with 1200 in 1989.1,2 Each month, almost twice as many patients are listed for transplantation as actually undergo the procedure.3 By December 1990, 49% of patients awaiting cardiac transplantation who are on the United Network of Organ Sharing (UNOS) waiting list had already been waiting for more than 6 months.1 Physician and patient expectations arise from these analyses of preceding years, which underestimate current waiting times. Many patients have now been waiting for more than 1 year, sometimes 2 years. As the waiting lists grow longer, many outpatients deteriorate to require hospitalization and urgent transplantation. 4 The pool of hospitalized candidates, who receive priority for the limited donor hearts, is composed largely of these deteriorating can-didates rather than those initially listed with urgent status. The waiting times are increasing for all candidates but particularly for the outpatients, who are receiving a decreasing proportion of the available donor hearts. Outpatients surviving long enough to receive donor hearts may be those who need them the least. 5 If current conditions prevail, how many hearts will ultimately be used for urgent transplantation? How often will outpatient candidates receive hearts? Using computer simulations of waiting list progression based on listing practices and waiting list risks, it is possible to predict the sizes of the waiting candidate populations and their expected outcomes. In addition, potential subgroups can be defined to examine the impact of changing criteria for candidate listing. Such information will allow reexamination of current policies and revision of current expectations for newly listed candidates.
Methods
Current conditions were defined (Table 1) according to information available from the Registry of the International Society of Heart and Lung Transplantation,6 UNOS,1-3 the Working Group of Transplant Cardiologists,7 and other published data. 5, 8, 9 In 1990 through 1991, there were approximately 300 patients newly listed each month for transplantation in the United States. National information sources do not report the proportion of patients initially listed as status I ("urgent" or "critical"), which requires hospitalization in an intensive care unit while receiving continuous infusions of In more recent experience from the last 100 patients listed at UCLA, 15% were initially listed as status I. Because status I patients have a higher priority for transplantation than do status II patients (all other candidates), they spend less time on the waiting list and make up a smaller proportion of the entire waiting list than do other candidates listed. Calculations were performed using both 15% and 25% as the proportion of candidates who were initially in critical status.
The number of transplants performed monthly was estimated from recent years to be 167, for which approximately 46% of recipients were urgent status.10 While waiting on the list, outpatients have an estimated 11% risk of sudden death and a 25% risk of deteriorating to urgent status, which was assumed to occur over a 6-month outpatient wait. These estimates are derived from data from 15 centers by the Working Group of Transplant Cardiologists (L.W. Miller, personal communication) and are unpublished but consistent with event rates for smaller series of cardiac transplantation candidates.58 '9 It was assumed that the number of donor hearts used remains virtually the same as it has for the past 3 years. The proportion of critical status candidates receiving hearts each month was calculated from the above data. Although these candidates receive priority, the constraints of blood type, body size, and location have limited the proportion of critical candidates receiving donor hearts each month to a current calculated proportion of 64%. Although this proportion might theoretically increase as the critical candidate waiting list grows larger, it was assumed to be constant over various waiting list sizes.
For simplicity, all patients listed as UNOS status II were considered as outpatients in this analysis, although in reality some hospitalized patients without critical decompensation are also status II. Postoperative survival statistics for the status I and status II recipients were derived from the International Society of Heart Transplant Registry6 and were used to calculate expected postoperative mortality according to the distribution of donor hearts.
A Markov chain model (see "Appendix") was constructed to determine the sizes and outcomes of the waiting list populations when an equilibrium is reached such that the number of patients joining the list each month is equal to the number of patients leaving the list as a result of transplantation or death.11,12 The overall annual mortality can then be calculated for a waiting outpatient, who may live or die with or without transplantation. The monthly chances of waiting patients to receive hearts were then calculated based on the current supply of donor hearts. To determine the sensitivity of the equilibrium population prediction to the estimated values for waiting list sudden death, deterioration, and hospital death, the 6-month event rates were altered by approximately 50% and the equilibrium state was recomputed.
Because the Markov chain model describes conditions when all populations have reached steady sizes, it cannot be used to determine how soon that equilibrium will be reached from current conditions. A month-by-month iterative model was then constructed from present conditions in which candidate listing as either outpatient or critical status, sudden death, deterioration from outpatient to critical status, death in hospital awaiting cardiac transplantation, and transplantation for either outpatients or critical patients were allowed to occur each month, until the equilibrium outpatient and critical status candidate pools reached a size within 5% of those predicted by the Markov chain model. The length of time required to reach equilibrium from current conditions was then defined. With this time, the variation in the predicted waiting list sizes and outcomes was determined as the assumed event rates were altered.
To see how an immediate reduction in the number of patients listed would affect eventual list conditions, the iterative model was redesigned, first by lowering the upper age limit for transplant candidates to 55 years. The impact of age reduction was calculated using the distribution of age among adult recipients for the past The equilibrium list lengths for outpatient and critical candidates, the proportion of hearts used for critical candi- 
Results

Equilibrium if Current Conditions Prevail
If current conditions prevail, there will eventually be almost 4000 candidates on the list for cardiac transplantation. This equilibrium list size predicted by the Markov chain model will essentially be achieved within 48 months, at which time there will be 3700 outpatients and 270 critical candidates, according to the month-bymonth iterative model ( Table 2 ). All hearts available will be used for the hospitalized candidates, 62% of whom can expect hearts within the next month. There will essentially be no hearts available for outpatient candidates (Fig 1) .
The number of candidates awaiting urgent transplantation is determined largely by the deterioration rate of patients initially listed for outpatient transplantation, of whom 170 will deteriorate to higher status each month at the equilibrium. This deteriorating population eclipses the proportion of patients initially listed as status I patients. If this proportion were assumed to be 0.25 instead of 0.15, equilibrium conditions would be similar but would be reached sooner, in 36 months, with 285 urgent status candidates and 3300 outpatient candidates. Even with this higher proportion of patients initially listed as urgent status, once equilibrium was reached, there would be twice as many candidates deteriorating to urgent status as being initially listed with urgent status. The subsequent results will be described assuming a proportion of 0.15.
Impact of Varying Estimates of Current Conditions
The sizes of equilibrium populations and monthly chances of receiving a donor heart for outpatient candidates were recalculated after varying the current estimates of outpatient sudden death, deterioration to urgent transplantation, and in-hospital death of critical candidates (Table 3) . Changing the expected deterioration rate caused the largest change in the predicted candidate population sizes. The chances for outpatient candidates were not markedly influenced, however, because the decline in critical candidates that results from a decline in deterioration rate maintains a much larger outpatient candidate pool among which to distribute the hearts made available for outpatient transplantation. Increasing the deterioration rate reduces the predicted outpatient candidate pool but expands the pool of critical candidates who then receive all donor hearts. Regardless of these broad estimate ranges, the monthly chance for a given outpatient to receive a donor heart will be no more than 1% if current listing practices continue for the next 48 months.
Impact of Changes in Listing Strategies
Decreasing the size of the candidate pool was examined first by imposing an upper age limit of 55 years.
This would be predicted to reduce the current waiting list by 30%, according to the recipient age distribution of transplant recipients in the International Registry,6 and it was assumed that this reduction would occur equally in the urgent candidate and outpatient candidate populations. Equilibrium would be reached by 3 years, with an urgent candidate population of 110 and an outpatient population of 1380. There would be 95 hearts available for the outpatients, who would then have a 7% chance of receiving a heart each month, which exceeds the chance under current conditions and greatly exceeds the chance if current conditions reach equilibrium (Fig 1) Table 2 ). By that time, there would be an 11% monthly chance for each outpatient to undergo transplantation. Selecting an outpatient population with a 90% risk would be associated with an even lower equilibrium population size. Listing a population with 70% yearly risk would give a bigger equilibrium outpatient candidate pool of 1450, but this is still smaller than the current outpatient list and less than half of the 3700 who will be on the list as outpatients at 48 months if the recent listing practices continue (Fig 2) .
The waiting list sizes determined at 48 months from the month-by-month iterative model were compared with those obtained at equilibrium in the Markov chain model. The predicted sizes of both the outpatient and critical candidate pools when listing patients at 52%, 60%, 70%, 80%, 90%, and 99% combined risks of sudden death or deterioration were within 5% of the equilibrium populations predicted for the Markov chain model.
Total Candidate Population Survival
As the balance between outpatient and urgent status transplantation shifts, posttransplantation survival is also affected. For an individual outpatient candidate, not only is pretransplantation death less likely, but posttransplantation survival is higher if he or she can undergo transplantation before deterioration. The International Registry data demonstrate that 30-day operative mortality is higher for urgent status recipients than for outpatient recipients.6 After discharge, survival is similar for the two groups. Including the perioperative mortality calculation according to strategies of listing showed a further benefit from strategies to reduce waiting list size when total deaths are considered (Table 2) . on the list. If the unlisted group of 55 to 65 years is still followed, however, the total effect of imposing a lower standard age limit would be to increase mortality without transplantation above that expected at the equilibrium predicted by current conditions, due primarily to the death of those older patients after deterioration. If the goal is to reduce the list while maximizing survival of the potential candidate population, those not listed should be those at the lowest risk. The estimated risks of the current population indicate that without transplantation, only half of the candidates will have died or deteriorated to status I after 1 year.5'9 Although these risks may vary from program to program, the fact that half of patients currently on the national waiting list have been waiting for more than 1 year indicates that extended survival without transplantation is frequent with current listing policies.
Perfect selection of the candidates who would die or deteriorate within the next year without transplantation is impossible, due in part to the multiple precipitating factors of both sudden death and deterioration.16 If our current selection could be refined, however, such that an outpatient population with an 80% 1-year risk is identified, the total waiting list size could be reduced by the 30%, which was described above for limitation by age instead. The deaths without transplantation would be minimized; fewer patients would have to deteriorate to receive transplantation; and total candidate death, with and without transplantation, would decrease to less than half of that expected per year if the current conditions persist until equilibrium in 48 months.
It should be possible to concentrate the candidate population more closely to those at an 80% risk without transplantation. Previous attempts to stratify risk were limited to the use of prognostic factors identified for a much wider spectrum, including mild to moderate heart failure. More recent information suggests that measurement of peak oxygen consumption, hemodynamic response to tailored vasodilator and diuretic therapy, and use of simple criteria for clinical stability will allow identification of outpatients likely to die or deteriorate after apparent stabilization.9'17,18 Improved understanding of the mechanisms of sudden death in heart failure will allow not only better risk stratification but also better prophylactic therapy, which may decrease the risks of sudden death in the clinically stable patient.19 '20 The immediate reduction of listed candidates according to risk would likely result in a true overall list reduction rather than a delay followed by a rebound increase the following year because current studies of these populations demonstrate the highest mortality to be in the early months after referral, after which death and deterioration occur at a relatively constant slow rate with no apparent late acceleration at least within the 2 years after initial evaluation. 5 Although the rigorous application of revised criteria for listing must await more specific information from ongoing studies of waiting list risk factors and outcomes, information currently available, as described above, does allow for immediate reduction in the number of patients listed. Such reduction is hampered by influence from referring physicians and families more keenly aware of the ravages of heart failure than of the consequences of infection and rejection after transplantation. Even after referral to transplantation, many patients with previous New York Heart Association functional class IV symptoms of heart failure can derive major benefit from optimal medical therapy and enjoy functional capacity similar to that achieved after trans- In addition to scientific advances in immunosuppression, the benefits actually realized from transplantation will also reflect trends in listing practices, which should be closely observed. For instance, the number of candidates newly listed each month has increased only slightly from 293 in 1990 to 310 in the first 6 months of 1993 (Timothy Breem, UNOS, personal communication). At the same time, however, the number of candidates removed each month from the list for reasons other than death or transplantation has increased from 32 in 1990 to 45 in 1993, perhaps reflecting an encouraging trend toward reevaluation. It will be important, however, to monitor initial listing changes closely, as current local incentives favor reducing the number of truly compromised candidates rather than those at lower risk.
Study Limitations
The models used in this study assume that monthly chances of transplantation, deterioration, or death remain constant from month to month, whereas the chance of receiving a transplant increases and the chance of dying or deteriorating actually decreases for the outpatient, which would make the prediction of interval risk easier after time.5 This study is limited by the validity of the assumptions about current conditions, which may vary from program to program. However, decrease in sudden death and deterioration rates would only cause the waiting list size to increase faster, as shown in Table 3 . Variation in the population of patients listed as urgent would change the rate at which equilibrium will be reached but would not significantly alter the conclusions regarding the imminent waiting list crisis or the approaches to its solution. The model is based on the current calculation that an appropriate donor can be found within 1 month for 64% of urgent candidates. Logistical considerations suggest that as the number of urgent candidates increases, any given donor will be more likely to be appropriate for at least one urgent candidate, so the proportion of hearts used for urgent candidates may increase even faster than predicted.
Implications
Faced with the impending waiting list crisis, we should currently provide more realistic expectations about the waiting time for outpatient candidates and focus on preventing sudden death and deterioration in this growing population. To improve overall survival by distributing the limited number of donor hearts to those who need them most, increasing effort must be devoted to identifying and listing only those patients who remain at highest risk for sudden death and deterioration without transplantation.
